MDM2 and cancer: When MDM2 is overexpressed, such as in cancer cells, it not only nullifies wt-p53 function by promoting p53 degradation but may also promote productive G2/M cell cycle phase transitions in rapidly proliferating cancer cells, a function which may contribute to its p53-independent oncogenic activity.